Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group

Abstract

Cheson, B.D., Greenberg, P.L., Bennett, J.M., Lowenberg, B., Wijermans, P.W., Nimer, S.D., Pinto, A., Beran, M., De Witte, T.M., Stone, R.M., Mittelman, M., Sanz, G.F., Gore, S.D., Schiffer, C.A. & Kantarjian, H. (2006) Clinical application and proposal for modification of the International Working Group (IWG) response criteria for myelodysplasia. Blood, 108, 419–425. Di Tucci, A.A., Murru, R., Alberti, D., Rabault, B., Deplano, S. & Angelucci, E. (2007) Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). European Journal of Haematology, 78, 540–542. Elli, E.M., Belotti, A., Aroldi, A., Parma, M., Pioltelli, P. & Pogliani, E.M. (2014) Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis. Mediterranean Journal of Hematology and Infectious Diseases, 6, e2014042. Isidori, A., Borin, L., Elli, E., Latagliata, R., Martino, B., Palumbo, G., Pilo, F., Loscocco, F., Visani, G. & Vianciulli, P. (2018) Iron toxicity – its effect on the bone marrow. Blood Reviews, 32, 473–479. Latagliata, R., Montagna, C., Porrini, R., Di Veroli, A., Leonetti, S.C., Niscola, P., Ciccone, F., Spadea, A., Breccia, M., Maurillo, L., Rago, A., Spirito, F., Cedrone, M., De Muro, M., Montanaro, M., Andriani, A., Bagnato, A., Montefusco, E. & Alimena, G. (2015) Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase. European Journal of Haematology, 96, 643–649. Pilo, F. & Angelucci, E. (2018) A storm in the niche: iron, oxidative stress and haemopoiesis. Blood Reviews, 32, 29–35. Piro, E., Lentini, M., Levato, L., Russo, A. & Molica, S. (2018) Sustained erythroid response in a patient with myelofibrosis receiving concomitant treatment with ruxolinib and deferasirox. Chemotherapy, 63, 107–110. Tefferi, A., Lasho, T.L., Jimma, T., Finke, C.M., Gangat, N., Vaidya, R., Begna, K.H., Al-Kali, A., Ketterling, R.P., Hanson, C.A. & Pardanani, A. (2012) One thousand patients with primary myelofibrosis: the mayo clinic experience. Mayo Clinic Proceedings, 87, 25–33. Zhang, Y., Zhai, W., Zhao, M., Li, D., Chai, X., Cao, X., Meng, J., Chen, J., Xiao, X., Li, Q., Mu, J., Shen, J. & Meng, A. (2015) Effects of iron overload on the bone marrow microenvironment in mice. PLoS ONE, 10, e0120219.